China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real-World Outcomes of Resected NSCLC patients treated with Adjuvant EGFR-TKI in China (ECHO)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132587
Registration Time: 2026/09/16
Type: Observational study
Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=324838
Published by HT Digital Content Services with permission from Health Daily Digest....